Literature DB >> 22161371

Antidepressants for cocaine dependence and problematic cocaine use.

Pier Paolo Pani1, Emanuela Trogu, Simona Vecchi, Laura Amato.   

Abstract

BACKGROUND: Cocaine dependence is a disorder for which no pharmacological treatment of proven efficacy exists, advances in the neurobiology could guide future medication development.
OBJECTIVES: To investigate the efficacy and acceptability of antidepressants alone or in combination with any psychosocial intervention for the treatment of cocaine dependence and problematic cocaine use. SEARCH
METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE and CINAHL in July 2011 and researchers for unpublished trials. SELECTION CRITERIA: Randomised clinical trials comparing antidepressants alone or associated with psychosocial intervention with placebo, no treatment, other pharmacological or psychosocial interventions. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial quality and extracted data. MAIN
RESULTS: 37 studies were included in the review (3551 participants).Antidepressants versus placebo: results for dropouts did not show evidence of difference, 31 studies, 2819 participants, RR 1.03 (Cl 95% 0.93 to 1.14). Looking at Abstinence from cocaine use, even though not statistically significant, the difference shown by the analysis in the three-weeks abstinence rate was in favour of antidepressants (eight studies, 942 participants, RR 1.22 (Cl 95% 0.99 to 1.51)). Considering only studies involving tricyclics, five studies, 367 participants, or only desipramine, four studies, 254 participants, the evidence was in favour of antidepressants. However, selecting only studies with operationally defined diagnostic criteria, statistical significance favouring antidepressants, as well as the trend for significance shown by the full sample, disappeared. Looking at safety issues, the results did not show evidence of differences (number of patients withdrawn for medical reasons, thirteen studies, 1396 participants, RR 1.39 (Cl 95% 0.91 to 2.12)). Subgroup analysis considering length of the trial, associated opioid dependence or associated psychosocial interventions as confounding factors, failed in showing consistent and statistically significant differences in favour of antidepressants.Antidepressants versus other drugs: Comparing antidepressants with dopamine agonists or with anticonvulsants, no evidence of differences was shown on dropouts and on other outcomes (abstinence from cocaine use, adverse events). AUTHORS'
CONCLUSIONS: At the current stage of evidence data do not support the efficacy of antidepressants in the treatment of cocaine abuse/dependence. Partially positive results obtained on secondary outcome measures, such as depression severity, do not seem to be associated with an effect on direct indicators of cocaine abuse/dependence. Antidepressants cannot be considered a mainstay of treatment for unselected cocaine abusers/dependents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22161371     DOI: 10.1002/14651858.CD002950.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  30 in total

1.  Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys by direct and indirect activation of 5-HT2C receptors.

Authors:  Daniela Rüedi-Bettschen; Roger D Spealman; Donna M Platt
Journal:  Psychopharmacology (Berl)       Date:  2015-04-17       Impact factor: 4.530

Review 2.  Agonist Medications for the Treatment of Cocaine Use Disorder.

Authors:  S Stevens Negus; Jack Henningfield
Journal:  Neuropsychopharmacology       Date:  2014-12-11       Impact factor: 7.853

3.  Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys.

Authors:  Louisa Degenhardt; Meyer Glantz; Sara Evans-Lacko; Ekaterina Sadikova; Nancy Sampson; Graham Thornicroft; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Laura Helena Andrade; Ronny Bruffaerts; Brendan Bunting; Evelyn J Bromet; José Miguel Caldas de Almeida; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Yueqin Huang; Aimee Karam; Elie G Karam; Andrzej Kiejna; Sing Lee; Jean-Pierre Lepine; Daphna Levinson; Maria Elena Medina-Mora; Yosikazu Nakamura; Fernando Navarro-Mateu; Beth-Ellen Pennell; José Posada-Villa; Kate Scott; Dan J Stein; Margreet Ten Have; Yolanda Torres; Zahari Zarkov; Somnath Chatterji; Ronald C Kessler
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

4.  Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer?

Authors:  Laura Brandt; Thomas Chao; Sandra D Comer; Frances R Levin
Journal:  Addiction       Date:  2020-09-28       Impact factor: 6.526

5.  Substance use outcomes in cocaine-dependent tobacco smokers: A mediation analysis exploring the role of sleep disturbance, craving, anxiety, and depression.

Authors:  Theresa M Winhusen; Jeff Theobald; Daniel F Lewis
Journal:  J Subst Abuse Treat       Date:  2018-10-26

6.  Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.

Authors:  Christopher D Verrico; Colin N Haile; James J Mahoney; Daisy G Y Thompson-Lake; Thomas F Newton; Richard De La Garza
Journal:  Drug Alcohol Depend       Date:  2014-05-28       Impact factor: 4.492

Review 7.  Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.

Authors:  William W Stoops; Craig R Rush
Journal:  Expert Rev Clin Pharmacol       Date:  2014-04-09       Impact factor: 5.045

8.  Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials.

Authors:  Maryam Bashiri; Michael J Mancino; Virginia A Stanick; Jeff Thostenson; Thomas R Kosten; Alison H Oliveto
Journal:  Am J Addict       Date:  2017-11-08

Review 9.  Psychostimulant addiction treatment.

Authors:  Karran A Phillips; David H Epstein; Kenzie L Preston
Journal:  Neuropharmacology       Date:  2014-04-12       Impact factor: 5.250

10.  Effects of escitalopram on attentional bias to cocaine-related stimuli and inhibitory control in cocaine-dependent subjects.

Authors:  Shijing Liu; Scott D Lane; Joy M Schmitz; Kathryn A Cunningham; Vineeth P John; F Gerard Moeller
Journal:  J Psychopharmacol       Date:  2013-06-12       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.